U.S. Stem Cell, Inc.【USRM】

Market cap

$64.15K

P/E ratio

	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022
Product	-	-	-	-	-	-	-	2	-	209,696	180,894	66,540
Service	-	-	-	-	-	-	-	5	-	67,391	19,855	15,509
Revenue	1	1	1	2	2	3	6	7	-	277,087	200,749	82,049
Cost of revenues	550,834	551,904	582,735	844,941	972,957	972,009	2	2	-	64,117	52,030	23,767
Gross profit	657,697	717,736	782,990	-	1	2	4	5	-	212,970	148,719	58,282
Selling, general and administrative	35	37	39	5	4	3	4	6	-	3	2	2
Total operating expenses	100	102	105	6	4	3	4	6	-	3	2	2
Loss from operations	-2,665,884	-2,534,843	-2,831,750	-3,529,452	-2,605,734	-1,159,559	-804,681	-1,097,903	-	-2,400,241	-2,135,858	-1,720,484
Gain (loss) on settlement of accounts payable and accrued interest, net	-	-	-	-	-	-	-	-	-	-	-	12
Interest expense	13	15	16	2	2	1	642,102	1	-	488,369	1	689,977
Gain (loss) on debt extinguishment	-	-	1	2	3	53,690	-126,457	5,625	-	182	-151,410	-447,494
Total other income (expense)	-2,031,153	-1,481,624	-311,509	1	963,854	-910,827	-2,676,810	-1,062,524	-	-490,252	-1,151,558	-1,137,459
Net loss before income taxes	-4,697,037	-4,016,467	-3,143,259	-2,253,511	-1,641,880	-2,070,386	-3,481,491	-2,160,427	-	-2,890,493	-3,287,416	-2,857,943
Income taxes (benefit)	-	-	-	-	-	-	-	-	-	-	-	-
NET LOSS	-4,697,037	-4,016,467	-3,143,259	-2,253,511	-1,641,880	-2,070,386	-3,481,491	-2,160,427	-	-2,890,493	-3,287,416	-2,857,943
Net loss per common share, basic and diluted (in Dollars per share)	-	-	-	-	-	-	-	-	-	-	-0.01	-